Journal Information
Original Article
Full text access
Available online 21 June 2024
Sex-specific Difference for Small Cell Lung Cancer from Immunotherapy Advancement
Diferencia sex-específica para el cáncer de pulmón de células pequeñas del avance de la inmunoterapia
You Moa,b, Yiwei Qinc, Jian Shangguanb, Duncan Weia, Meng Wub, Dawei Chenb,1,
, Jinming Yua,b,1,
Corresponding author
Corresponding author
a Laboratory of Molecular Cardiology, The First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China
b Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China
c Cheeloo College of Medicine, Shandong University
Highlights
- •
Provided the first evidence of a significant difference in immunotherapy advance among sex for SCLC based population mortality. Patient with SCLC in women benefit significantly.
Statistics
Follow this link to access the full text of the article
Original Article
Sex-specific Difference for Small Cell Lung Cancer from Immunotherapy Advancement
Diferencia sex-específica para el cáncer de pulmón de células pequeñas del avance de la inmunoterapia
You Moa,b, Yiwei Qinc, Jian Shangguanb, Duncan Weia, Meng Wub, Dawei Chenb,1,
, Jinming Yua,b,1,
Corresponding author
Corresponding author
a Laboratory of Molecular Cardiology, The First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China
b Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China
c Cheeloo College of Medicine, Shandong University